Assessing the utility of a community pharmacy refill record as a measure of adherence and viral load response in patients infected with human immunodeficiency virus

被引:15
作者
Inciardi, JE [1 ]
Leeds, AL [1 ]
机构
[1] Univ Calif San Francisco, Sch Pharm, Dept Clin Pharm, San Francisco, CA 94143 USA
来源
PHARMACOTHERAPY | 2005年 / 25卷 / 06期
关键词
viral load; HIV; antiretroviral drugs; AIDS; drug compliance; pharmacy refill record;
D O I
10.1592/phco.2005.25.6.790
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Study Objective. To assess the utility of a community pharmacy refill record as a measure of adherence to antiretroviral agents and as a predictor of viral load response. Design. Retrospective review of laboratory and community pharmacy records. Setting. University-based human immunodeficiency virus (HIV) clinic and local community pharmacy. Patients. Ninety-four patients with HIV or the acquired immunodeficiency syndrome (AIDS) who visited both settings and had retrievable pharmacy and laboratory records. Measurements and Main Results. Community pharmacy records were compiled and screened for antiretroviral agent refill histories. The continuous, multiple-interval measure of medication gaps (CMG), a measure of drug nonadherence, was calculated for each antiretroviral agent. Viral load information was retrieved from the clinic records of patients who had a community pharmacy refill record documenting the previous 2 years. As refill nonadherence increased, viral load response increased, following an approximately sigmoid relationship. When the CMG score was less than 0.10, the viral load response did not change appreciably. The steepest rise in viral load response occurred with a CMG score ranging from 0.10- 0.19. For values of 0.20 or greater, the viral load response was less sensitive to adherence performance. The probability (i.e., sensitivity) of having at least a 10% nonadherence record given a viral load greater than 1000 copies/ml was 80%. Conclusion. The community pharmacy refill record is a convenient, accessible, and useful tool for assessing adherence and predicting viral load outcomes in patients with HIV and AIDS.
引用
收藏
页码:790 / 796
页数:7
相关论文
共 16 条
[1]   Non-adherence to highly active antiretroviral therapy predicts progression to AIDS [J].
Bangsberg, DR ;
Perry, S ;
Charlebois, ED ;
Clark, RA ;
Roberston, M ;
Zolopa, AR ;
Moss, A .
AIDS, 2001, 15 (09) :1181-1183
[2]  
Bangsberg DR, 2001, J ACQ IMMUN DEF SYND, V26, P435, DOI 10.1097/00126334-200104150-00005
[3]  
Bartlett John G, 2003, Hopkins HIV Rep, V15, P8
[4]   Adherence to HAART regimens [J].
Chesney, M .
AIDS PATIENT CARE AND STDS, 2003, 17 (04) :169-177
[5]  
Cinti S K, 2000, AIDS Read, V10, P709
[6]   ROBUST LOCALLY WEIGHTED REGRESSION AND SMOOTHING SCATTERPLOTS [J].
CLEVELAND, WS .
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1979, 74 (368) :829-836
[7]   Provider inaccuracy in assessing adherence and outcomes with newly initiated antiretroviral therapy [J].
Gross, R ;
Bilker, WB ;
Friedman, HM ;
Coyne, JC ;
Strom, BL .
AIDS, 2002, 16 (13) :1835-1837
[8]   Factors associated with accurate self-reported adherence to HIV antiretrovirals [J].
Kimmerling, M ;
Wagner, G ;
Ghosh-Dastidar, B .
INTERNATIONAL JOURNAL OF STD & AIDS, 2003, 14 (04) :281-284
[9]   Prevalence, predictors, and outcomes of early adherence after starting or changing antiretroviral therapy [J].
Mathews, WC ;
Mar-Tang, M ;
Ballard, C ;
Colwell, B ;
Abulhosn, K ;
Noonan, C ;
Barber, RE ;
Wall, TL .
AIDS PATIENT CARE AND STDS, 2002, 16 (04) :157-172
[10]   No evidence of an association between transient HIV viremia ("blips") and lower adherence to the antiretroviral medication regimen [J].
Miller, LG ;
Golin, CE ;
Liu, HH ;
Hays, RD ;
Hua, J ;
Wenger, NS ;
Kaplan, AH .
JOURNAL OF INFECTIOUS DISEASES, 2004, 189 (08) :1487-1496